Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedNov 24, 2024
DataAggregated Company Financials
Companies29
  • 7D0.9%
  • 3M-15.9%
  • 1Y9.3%
  • YTD-4.8%

Over the last 7 days, the Pharma industry has remained flat, although notably Swedencare gained 3.3%. As for the the longer term, the industry is up 9.3% over the past 12 months. As for the next few years, earnings are expected to grow by 73% per annum.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 24 Nov 2024SEK 50.3bSEK 4.4b-SEK 619,523,619.23126.6x-81.1x11.3x
Tue, 22 Oct 2024SEK 53.8bSEK 4.3b-SEK 677,049,733.70136.8x-79.5x12.6x
Thu, 19 Sep 2024SEK 66.5bSEK 5.9b-SEK 1,169,990,593.21174.1x-56.8x11.3x
Sat, 17 Aug 2024SEK 70.1bSEK 5.9b-SEK 946,905,019.7090.4x-74x11.9x
Mon, 15 Jul 2024SEK 69.5bSEK 6.4b-SEK 835,140,932.6385.7x-83.2x10.9x
Wed, 12 Jun 2024SEK 62.1bSEK 6.4b-SEK 862,468,692.5777x-72x9.8x
Fri, 10 May 2024SEK 51.2bSEK 6.4b-SEK 803,411,675.6668.4x-63.8x8x
Sun, 07 Apr 2024SEK 51.4bSEK 6.2b-SEK 1,038,130,822.6777.9x-49.6x8.2x
Tue, 05 Mar 2024SEK 48.4bSEK 6.2b-SEK 1,038,055,453.8080.7x-46.6x7.8x
Thu, 01 Feb 2024SEK 68.7bSEK 9.5b-SEK 1,181,774,794.0064.9x-58.1x7.3x
Sat, 30 Dec 2023SEK 68.6bSEK 9.4b-SEK 1,184,243,785.0065.1x-58x7.3x
Mon, 27 Nov 2023SEK 61.2bSEK 9.5b-SEK 1,174,445,030.0054.4x-52.1x6.5x
Wed, 25 Oct 2023SEK 50.4bSEK 9.2b-SEK 1,143,109,792.00102.3x-44.1x5.5x
Fri, 22 Sep 2023SEK 51.6bSEK 9.2b-SEK 1,177,928,668.00135.7x-43.8x5.6x
Sun, 20 Aug 2023SEK 50.6bSEK 9.1b-SEK 1,308,392,355.0082.1x-38.7x5.5x
Tue, 18 Jul 2023SEK 48.5bSEK 8.4b-SEK 1,693,190,163.0084.4x-28.7x5.8x
Thu, 15 Jun 2023SEK 48.2bSEK 8.4b-SEK 1,728,123,085.0077.8x-27.9x5.8x
Sat, 13 May 2023SEK 49.7bSEK 8.2b-SEK 1,783,516,878.0090.8x-27.9x6.1x
Mon, 10 Apr 2023SEK 46.4bSEK 8.0b-SEK 1,793,930,310.0088x-25.8x5.8x
Wed, 08 Mar 2023SEK 44.6bSEK 8.0b-SEK 1,790,717,955.0088.2x-24.9x5.6x
Fri, 03 Feb 2023SEK 47.7bSEK 7.3b-SEK 1,966,129,241.00292.9x-24.2x6.5x
Sun, 01 Jan 2023SEK 48.0bSEK 7.3b-SEK 1,910,765,999.00283.1x-25.1x6.6x
Tue, 29 Nov 2022SEK 50.5bSEK 7.3b-SEK 1,876,545,519.00330.1x-26.9x6.9x
Thu, 27 Oct 2022SEK 49.5bSEK 7.0b-SEK 1,754,469,143.0050x-28.2x7.1x
Sat, 24 Sep 2022SEK 48.9bSEK 7.0b-SEK 1,739,821,936.0047x-28.1x7x
Mon, 22 Aug 2022SEK 53.3bSEK 6.9b-SEK 1,783,375,850.0061.4x-29.9x7.7x
Wed, 20 Jul 2022SEK 49.8bSEK 6.0b-SEK 1,414,388,648.0043.2x-35.2x8.3x
Fri, 17 Jun 2022SEK 50.1bSEK 5.9b-SEK 1,509,116,648.0042.9x-33.2x8.5x
Sun, 15 May 2022SEK 47.8bSEK 5.6b-SEK 1,206,911,761.0042.7x-39.6x8.5x
Tue, 12 Apr 2022SEK 55.3bSEK 5.5b-SEK 1,336,664,342.0039.4x-41.4x10x
Thu, 10 Mar 2022SEK 49.5bSEK 5.4b-SEK 1,389,013,613.0030.2x-35.7x9.1x
Sat, 05 Feb 2022SEK 51.9bSEK 5.3b-SEK 1,043,861,217.0091.7x-49.8x9.8x
Mon, 03 Jan 2022SEK 58.5bSEK 5.5b-SEK 1,100,183,162.00125x-53.2x10.7x
Wed, 01 Dec 2021SEK 56.7bSEK 5.5b-SEK 1,097,623,199.00126.2x-51.7x10.4x
Price to Earnings Ratio

-51.7x


Total Market Cap: SEK 56.7bTotal Earnings: -SEK 1,097,623,199.00Total Revenue: SEK 5.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -44x202220232024
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.0x is lower than the industry's current PS ratio of 11.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 6.6% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.23%
Healthcare-0.69%
Pharma0.86%
Pharma0.86%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SECARE SwedencareSEK 46.283.3%
+SEK 235.1m		-20.0%PE118.4x
CAMX CamurusSEK 573.000.5%
+SEK 176.4m		27.2%PE126.6x
MOB Moberg PharmaSEK 18.2611.8%
+SEK 89.7m		77.3%PS97.1x
FLERIE FlerieSEK 45.301.8%
+SEK 62.8m		n/an/a
CESSA CessatechDKK 14.407.9%
+DKK 18.3m		235.7%PS74.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SECARE

SEK 46.28

Swedencare

7D

3.3%

1Y

-20.0%

DANCAN

DKK 0.012

DanCann Pharma

7D

241.2%

1Y

-74.8%

IRLAB A

SEK 13.10

IRLAB Therapeutics

7D

-6.4%

1Y

94.9%

MOB

SEK 18.26

Moberg Pharma

7D

11.8%

1Y

77.3%

ALZCUR

SEK 1.05

AlzeCure Pharma

7D

-17.0%

1Y

-72.7%

KDEV

SEK 1.04

Karolinska Development

7D

4.2%

1Y

-42.7%

CAMX

SEK 573.00

Camurus

7D

0.5%

1Y

27.2%

Investors Can Find Comfort In Camurus' (STO:CAMX) Earnings Quality

Nov 15
Investors Can Find Comfort In Camurus' (STO:CAMX) Earnings Quality

IBT B

SEK 38.20

Infant Bacterial Therapeutics

7D

4.1%

1Y

-58.6%

LIPI

SEK 0.12

Lipidor

7D

-11.7%

1Y

-84.0%

CINPHA

SEK 20.01

Cinclus Pharma Holding

7D

-3.6%

1Y

n/a

ORX

SEK 9.55

Orexo

7D

-4.9%

1Y

-35.7%

Orexo AB (publ) (STO:ORX) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Nov 05
Orexo AB (publ) (STO:ORX) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

ONCOZ

SEK 3.50

OncoZenge

7D

-59.1%

1Y

-0.1%

NEWBRY

SEK 3.32

Newbury Pharmaceuticals

7D

-13.1%

1Y

-8.8%

FLERIE

SEK 45.30

Flerie

7D

1.8%

1Y

n/a

CESSA

DKK 14.40

Cessatech

7D

7.9%

1Y

235.7%

ANNX

SEK 0.47

Annexin Pharmaceuticals

7D

-3.7%

1Y

-41.8%